Preclinical, Clinical Trials & Diagnostics

Immuno-oncology & Oncology

お問い合わせ

Your one source to achieve your next cancer breakthrough

More than half a million people with cancer will die this year; our mission is to be your one source to improve people's health and lives. 

From hundreds of preclinical tumor models and cell line assays to oncology clinical trials and post-market studies, we can help you get your next breakthrough cancer drug or precision medicine treatment to those who desperately need it.

より公平な癌治療のための血液検査の役割

We're committed to helping you and your loved ones find personalized cancer care options. That's why we teamed up with WIRED Brand Lab to show how our simple blood test is making targeted cancer therapies more accessible. Produced by WIRED Brand Lab with Labcorp.

治験

In the last five years, our expertise, insights and market impact have been demonstrated in excess of 975 oncology studies (300 in immuno-oncology) across nearly 19,000 sites in 83 countries with more than 104,000 oncology patients. 

Embrace a personalized medicine approach that targets therapies to specific subsets of patients and begins in the preclinical phase of drug development. 

今日の患者様サポートプログラムの中心を占めているものに「テクノロジー」がありますが、テクノロジーは万能なものではありません。効率とリスクの均衡を適切にするためには、テクノロジーと人、そしてプロセス間でのでバランスが必要です。
Utilize biomarkers in clinical oncology development to provide key data for earlier decision making as well as patient and site selection

 

Codevelop a drug with oncology companion diagnostics to help identify patients most likely to benefit from your next cancer breakthrough

Preclinical immunotherapy

業界はimmuno-oncology に様々な角度からアプローチしています。したがって、関連性があり、適切なエンドポイントを含む最適な生物動態を簡潔に説明できるモデルの判別、開発、そして改良が求められています。

Precision medicine and clinical trials

治験のプレシジョンメディシンにおいて進歩を遂げるには、最適な治療法を迅速にテストし、最適な人物に的を絞る新規の方法が求められています。幾十の後期Immuno-Oncology治験の他にも、当社ではすべての米国食品医薬品局(FDA)の承認を受けたコンパニオン診断製品の70%以上を支援してきました。

Oncology resources and education

Oncology events and webinars

The Patient Journey in CAR T: Patient & Physician Perspectives
 

お問い合わせはこちら

お問い合わせ